Advertisement

 

 

Determinants of community pharmacists’ quality of care: a population-based cohort study using pharmacy administrative claims data.

Determinants of community pharmacists’ quality of care: a population-based cohort study using pharmacy administrative claims data.
Author Information (click to view)

Winslade N, Tamblyn R,


Winslade N, Tamblyn R, (click to view)

Winslade N, Tamblyn R,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

BMJ open 2017 09 217(9) e015877 doi 10.1136/bmjopen-2017-015877
Abstract
OBJECTIVE
To determine if a prototype pharmacists’ services evaluation programme that uses linked community pharmacy claims and health administrative data to measure pharmacists’ performance can be used to identify characteristics of pharmacies providing higher quality of care.

DESIGN
Population-based cohort study using community pharmacy claims from 1 November 2009 to 30 June 2010.

SETTING
All community pharmacies in Quebec, Canada.

PARTICIPANTS
1742 pharmacies dispensing 8 655 348 antihypertensive prescriptions to 760 700 patients.

PRIMARY OUTCOME MEASURE
Patient adherence to antihypertensive medications.

PREDICTORS
Pharmacy level: dispensing workload, volume of pharmacist-provided professional services (eg, refusals to dispense, pharmacotherapy recommendations), pharmacy location, banner/chain, pharmacist overlap and within-pharmacy continuity of care. Patient level: sex, age, income, patient prescription cost, new/chronic therapy, single/multiple antihypertensive medications, single/multiple prescribers and single/multiple dispensing pharmacies. Dispensing level: prescription duration, time of day dispensed and antihypertensive class. Multivariate alternating logistic regression estimated predictors of the primary outcome, accounting for patient and pharmacy clustering.

RESULTS
9.2% of dispensings of antihypertensive medications were provided to non-adherent patients. Male sex, decreasing age, new treatment, multiple prescribers and multiple dispensing pharmacies were risk factors for increased non-adherence. Pharmacies that provided more professional services were less likely to dispense to non-adherent hypertensive patients (OR: 0.60; 95% CI: 0.57 to 0.62) as were those with better scores on the Within-Pharmacy Continuity of Care Index. Neither increased pharmacists’ services for improving antihypertensive adherence per se nor increased pharmacist overlap impacted the odds of non-adherence. However, pharmacist overlap was strongly correlated with dispensing workload. There was significant unexplained variability among pharmacies belonging to different banners and chains.

CONCLUSIONS
Pharmacy administrative claims data can be used to calculate pharmacy-level characteristics associated with improved quality of care. This study supports the importance of pharmacist’s professional services and continuity of pharmacist’s care.

Submit a Comment

Your email address will not be published. Required fields are marked *

one × four =

[ HIDE/SHOW ]